Company
United StatesUSC Reproductive Endocrinology and Infertility, Los Angeles, CA – FDA Inspections
Inspection records and compliance data for USC Reproductive Endocrinology and Infertility in Los Angeles, California. 3 FDA inspections on record, last inspected March 21, 2019.
Company Profile
This profile covers USC Reproductive Endocrinology and Infertility based in Los Angeles, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected June 24, 2011. Last inspected March 21, 2019.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 21, 2019 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1085858 |
| June 15, 2016 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 986030 |
| June 24, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 732291 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
USC Reproductive Endocrinology and Infertility
FEI Number
3004715781
Address
1127 Wilshire Blvd Ste 1400, Los Angeles, California 90017, United States
Country
United States
ID: 1f152fa8-3c0b-4997-b214-9ef6504d8658